NCX1 was validated as a target of miR-103-1 in cortical neurons, and intracerebroventricular infusion of anti-miR-103-1 not only prevented NCX1 reduction induced by stroke but also significantly reduced the extent of brain ischemia when infused 24 h before stroke onset (112). Here, SLC8A1 is linked to stroke disorder.